Zeynep Biyik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zeynep Biyik has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Lütfullah Altintepe
Division of Nephrology, Department of Internal Medicine, Selcuk University Faculty of Medicine, Konya, Turkey
2 shared publicationsYasemin Coskun Yavuz
Division of Nephrology, Department of Internal Medicine, Selcuk University Faculty of Medicine, Konya, Turkey
2 shared publications/ Konya
Selçuk Üniversitesi Tıp Fakültesi Nefroloji Bilim Dalı Selçuklu Konya
1 shared publicationA Cizmecioglu
Department of Internal Medicine, Selcuk University Faculty of Medicine, Konya, Turkey
1 shared publication- Abduzhappar Gaipov
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
1 shared publication - Adrian Covic
Grigore T. Popa University of Medicine and Pharmacy Iasi, 700115 Iași, Romania
1 shared publication
Latest Publications
- Open Access
- 4 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7834
Eight-Year Retrospective Analysis of Mortality in Patients with Moderate to Severe Hyponatremia: A Comprehensive Study
Background/Objectives: Hyponatremia is defined as a serum sodium concentration below 135 mEq/L. It is associated with increased morbidity and mortality. This study aimed to determine the factors associated with mortality in patients hospitalized with moderate to severe hyponatremia in the nephrology clinic and nephrology intensive care unit during an eight-year follow-up period. Methods: This retrospective study included patients admitted between January 2018 and October 2025 who were hospitalized due to moderate or severe hyponatremia. Results: Of 4270 patients, 337 (7.8%) were hospitalized with moderate to severe hyponatremia. The majority of patients were female (60.2%; n = 203). 242 patients (71.8%) had severe hyponatremia. The most common presenting complaint was nausea and vomiting, the most common month and season of presentation was July-Summer, and the most common cause of hyponatremia was drug-induced hyponatremia. The mortality rate was 40.7% (n = 137). The most common cause of death was decompensated heart failure. Factors independently affecting mortality; age (HR = 1.018, 95% CI 1.001–1.037, p = 0.047), malignancy (HR = 2.397, 95% CI 1.459–3.939, p < 0.001), number of hospitalizations (HR = 0.377, 95% CI 0.228–0.623, p < 0.001), EF (HR = 0.972, 95% CI 0.956–0.988, p < 0.001), high phosphorus (HR = 2.397, 95% CI 1.527–3.764, p < 0.001), furosemide use (HR = 1.638, 95% CI 1.018–2.636, p = 0.042) and fluid restriction. Conclusions: Advanced age, malignancy, high phosphorus levels, furosemide use, and fluid restriction were associated with increased mortality, whereas higher ejection fraction and greater number of hospitalizations were protective. These findings emphasize the importance of individualized management strategies and close follow-up in patients with moderate to severe hyponatremia.
- 4 November 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7834
Open AccessEight-Year Retrospective Analysis of Mortality in Patients with Moderate to Severe Hyponatremia: A Comprehensive Study
Background/Objectives: Hyponatremia is defined as a serum sodium concentration below 135 mEq/L. It is associated with increased morbidity and mortality. This study aimed to determine the factors associated with mortality in patients hospitalized with moderate to severe hyponatremia in the nephrology clinic and nephrology intensive care unit during an eight-year follow-up period. Methods: This retrospective study included patients admitted between January 2018 and October 2025 who were hospitalized due to moderate or severe hyponatremia. Results: Of 4270 patients, 337 (7.8%) were hospitalized with moderate to severe hyponatremia. The majority of patients were female (60.2%; n = 203). 242 patients (71.8%) had severe hyponatremia. The most common presenting complaint was nausea and vomiting, the most common month and season of presentation was July-Summer, and the most common cause of hyponatremia was drug-induced hyponatremia. The mortality rate was 40.7% (n = 137). The most common cause of death was decompensated heart failure. Factors independently affecting mortality; age (HR = 1.018, 95% CI 1.001–1.037, p = 0.047), malignancy (HR = 2.397, 95% CI 1.459–3.939, p < 0.001), number of hospitalizations (HR = 0.377, 95% CI 0.228–0.623, p < 0.001), EF (HR = 0.972, 95% CI 0.956–0.988, p < 0.001), high phosphorus (HR = 2.397, 95% CI 1.527–3.764, p < 0.001), furosemide use (HR = 1.638, 95% CI 1.018–2.636, p = 0.042) and fluid restriction. Conclusions: Advanced age, malignancy, high phosphorus levels, furosemide use, and fluid restriction were associated with increased mortality, whereas higher ejection fraction and greater number of hospitalizations were protective. These findings emphasize the importance of individualized management strategies and close follow-up in patients with moderate to severe hyponatremia.
- Open Access
- 1 March 2025
- Published by Wolters Kluwer Health in Nigerian Journal of Clinical Practice
- Vol. 28 (3) , 360-366
The Role of the BUN/Albumin Ratio in Predicting Poor Clinical Outcomes in Patients with Acute Pancreatitis
Background: The blood urea nitrogen (BUN) to albumin ratio (BAR) has emerged as a potential prognostic marker in various pathological states. Aim: This study aims to elucidate the utility of BAR in predicting the incidence of acute kidney injury (AKI) and severe acute pancreatitis (SAP) in patients diagnosed with acute pancreatitis (AP). Methods: This retrospective analysis included 210 patients diagnosed with AP and monitored at a tertiary university hospital. Patients were classified into three categories based on the severity of pancreatitis: mild AP, moderately severe AP, and severe AP. Results: BAR levels increased significantly with the progression of disease severity ( P < 0.001). Median BAR values were 3.3 for mild AP, 3.9 for moderately severe AP, and 11.6 for severe AP. In multivariate regression analysis, BAR was identified as an independent prognostic factor for both severe AP (odds ratio [OR] =1.341, 95% confidence interval [CI]: 1.016–1.612, P = 0.002) and AKI (OR = 1.382, 95% CI: 1.138–1.679, P = 0.001). Receiver operating characteristic (ROC) analysis indicated that a BAR threshold exceeding 5.192 predicted severe AP with a sensitivity (Sn) of 71.4% and specificity (Sp) of 82.5% (area under the curve [AUC] =0.849, P < 0.001). Additionally, a BAR threshold greater than 4.505 was found to predict AKI with a Sn of 63.2% and Sp of 86.6% (AUC = 0.782, P < 0.001). Conclusion: BAR, assessed at hospital admission, demonstrates considerable promise as a readily accessible biomarker for predicting the severity of AP and the development of AKI.
- 1 March 2025
- Published by Wolters Kluwer Health in Nigerian Journal of Clinical Practice
- Vol. 28 (3) , 360-366
Open AccessThe Role of the BUN/Albumin Ratio in Predicting Poor Clinical Outcomes in Patients with Acute Pancreatitis
Background: The blood urea nitrogen (BUN) to albumin ratio (BAR) has emerged as a potential prognostic marker in various pathological states. Aim: This study aims to elucidate the utility of BAR in predicting the incidence of acute kidney injury (AKI) and severe acute pancreatitis (SAP) in patients diagnosed with acute pancreatitis (AP). Methods: This retrospective analysis included 210 patients diagnosed with AP and monitored at a tertiary university hospital. Patients were classified into three categories based on the severity of pancreatitis: mild AP, moderately severe AP, and severe AP. Results: BAR levels increased significantly with the progression of disease severity ( P < 0.001). Median BAR values were 3.3 for mild AP, 3.9 for moderately severe AP, and 11.6 for severe AP. In multivariate regression analysis, BAR was identified as an independent prognostic factor for both severe AP (odds ratio [OR] =1.341, 95% confidence interval [CI]: 1.016–1.612, P = 0.002) and AKI (OR = 1.382, 95% CI: 1.138–1.679, P = 0.001). Receiver operating characteristic (ROC) analysis indicated that a BAR threshold exceeding 5.192 predicted severe AP with a sensitivity (Sn) of 71.4% and specificity (Sp) of 82.5% (area under the curve [AUC] =0.849, P < 0.001). Additionally, a BAR threshold greater than 4.505 was found to predict AKI with a Sn of 63.2% and Sp of 86.6% (AUC = 0.782, P < 0.001). Conclusion: BAR, assessed at hospital admission, demonstrates considerable promise as a readily accessible biomarker for predicting the severity of AP and the development of AKI.
- 5 June 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (8) , 1613-1620
Systemic Inflammation Response Index and Systemic Immune Inflammation Index Are Associated with Clinical Outcomes in Patients with Acute Pancreatitis?
Objectives: The inflammatory response is critically important in acute pancreatitis (AP). Systemic immune-inflammation (SII) index and systemic inflammation response index (SIRI), which are novel inflammatory markers, have been linked to determining outcomes in various diseases. The goal of the current study was to examine the relation of the SII index and SIRI with disease severity and acute kidney injury (AKI) in subjects with AP. Methods: A total of 332 subjects with AP were analyzed retrospectively. SII index was calculated using the formula; platelet (P)×neutrophil (N)/lymphocyte (L), while SIRI was calculated as N × monocyte (M)/L count. Multivariate regression (MR) was done to determine the independent risk factors for AKI and severe AP (SAP). Results: Statistical analyses showed that both median SII index and median SIRI increased gradually with higher AP severity (p < 0.001). Both SII index and SIRI were higher in subjects with AKI compared to controls (p < 0.001). Using MR analysis, the SII index was found to independently predict both SAP (OR = 1.004, 95% CI: 1.001–1.008, p = 0.018) and AKI (OR = 1.005, 95% CI: 1.003–1.008, p < 0.001). ROC analysis showed that the SII index could accurately differentiate SAP (AUC = 0.809, p < 0.001) and AKI (AUC = 0.820, p = 0.001) in patients with acute pancreatitis. ROC analysis also showed that SIRI could also accurately differentiate SAP (0.782, p < 0.001) and AKI (AUC = 0.776, p = 0.001). Conclusions: SIRI and the SII indexes can be used as potential biomarkers in predicting both disease severity and AKI development in subjects with AP.
- 5 June 2022
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 35 (8) , 1613-1620
Systemic Inflammation Response Index and Systemic Immune Inflammation Index Are Associated with Clinical Outcomes in Patients with Acute Pancreatitis?
Objectives: The inflammatory response is critically important in acute pancreatitis (AP). Systemic immune-inflammation (SII) index and systemic inflammation response index (SIRI), which are novel inflammatory markers, have been linked to determining outcomes in various diseases. The goal of the current study was to examine the relation of the SII index and SIRI with disease severity and acute kidney injury (AKI) in subjects with AP. Methods: A total of 332 subjects with AP were analyzed retrospectively. SII index was calculated using the formula; platelet (P)×neutrophil (N)/lymphocyte (L), while SIRI was calculated as N × monocyte (M)/L count. Multivariate regression (MR) was done to determine the independent risk factors for AKI and severe AP (SAP). Results: Statistical analyses showed that both median SII index and median SIRI increased gradually with higher AP severity (p < 0.001). Both SII index and SIRI were higher in subjects with AKI compared to controls (p < 0.001). Using MR analysis, the SII index was found to independently predict both SAP (OR = 1.004, 95% CI: 1.001–1.008, p = 0.018) and AKI (OR = 1.005, 95% CI: 1.003–1.008, p < 0.001). ROC analysis showed that the SII index could accurately differentiate SAP (AUC = 0.809, p < 0.001) and AKI (AUC = 0.820, p = 0.001) in patients with acute pancreatitis. ROC analysis also showed that SIRI could also accurately differentiate SAP (0.782, p < 0.001) and AKI (AUC = 0.776, p = 0.001). Conclusions: SIRI and the SII indexes can be used as potential biomarkers in predicting both disease severity and AKI development in subjects with AP.
- 1 July 2020
- Published by Springer Nature in Sleep and Biological Rhythms
- Vol. 18 (3) , 267-273
Restless legs syndrome and arterial stiffness in pre-dialysis chronic kidney disease
- 1 July 2020
- Published by Springer Nature in Sleep and Biological Rhythms
- Vol. 18 (3) , 267-273
Restless legs syndrome and arterial stiffness in pre-dialysis chronic kidney disease
- 8 June 2020
- Published by Springer Nature in International Urology and Nephrology
- Vol. 52 (10) , 1935-1941
Association between serum magnesium and anemia in patients with chronic kidney disease
Purpose An inverse association was shown between serum magnesium levels and anemia in the general population. However, limited information is available about the association between serum magnesium level and anemia in the patient population with chronic kidney disease. We aimed to investigate the relationship between hypomagnesemia and anemia in pre-dialysis patients with chronic kidney disease stage 3–5. Methods This cross-sectional retrospective study included 213 chronic kidney disease patients with an estimated glomerular filtration rate of 60 mL/min and below. Laboratory and demographic data of outpatients were collected in January 2018—January 2019. Patients with a magnesium level below 1.9 mg/dL were accepted as the hypomagnesemia group. Results Serum magnesium level of 62 (29.1%) of these patients were below 1.9 mg/dL. Compared with normomagnesemic patients, hypomagnesemic patients had lower mean hemoglobin values (11.3 g/dL vs. 12.7 g/dL, P < 0.001), proton-pump inhibitor usage rates were significantly higher (33.9% vs. 17.2%, P = 0.008) and the median urine protein/creatinine ratio was found to be significantly higher (1017.5 mg/gCr vs. 536 mg/gCr, P = 0.045). In the multivariate analysis, the use of hemoglobin (OR 0.634; 95% CI 0.505–0.795; P < 0.001) and proton-pump inhibitor (OR 2.670; 95% CI 1.113–6.318; P = 0.025) were independent predictors of hypomagnesemia. Conclusions Hypomagnesemia is a common electrolyte disorder in pre-dialysis CKD patients. In this patient group, anemia is independently associated with hypomagnesemia.
- 8 June 2020
- Published by Springer Nature in International Urology and Nephrology
- Vol. 52 (10) , 1935-1941
Association between serum magnesium and anemia in patients with chronic kidney disease
Purpose An inverse association was shown between serum magnesium levels and anemia in the general population. However, limited information is available about the association between serum magnesium level and anemia in the patient population with chronic kidney disease. We aimed to investigate the relationship between hypomagnesemia and anemia in pre-dialysis patients with chronic kidney disease stage 3–5. Methods This cross-sectional retrospective study included 213 chronic kidney disease patients with an estimated glomerular filtration rate of 60 mL/min and below. Laboratory and demographic data of outpatients were collected in January 2018—January 2019. Patients with a magnesium level below 1.9 mg/dL were accepted as the hypomagnesemia group. Results Serum magnesium level of 62 (29.1%) of these patients were below 1.9 mg/dL. Compared with normomagnesemic patients, hypomagnesemic patients had lower mean hemoglobin values (11.3 g/dL vs. 12.7 g/dL, P < 0.001), proton-pump inhibitor usage rates were significantly higher (33.9% vs. 17.2%, P = 0.008) and the median urine protein/creatinine ratio was found to be significantly higher (1017.5 mg/gCr vs. 536 mg/gCr, P = 0.045). In the multivariate analysis, the use of hemoglobin (OR 0.634; 95% CI 0.505–0.795; P < 0.001) and proton-pump inhibitor (OR 2.670; 95% CI 1.113–6.318; P = 0.025) were independent predictors of hypomagnesemia. Conclusions Hypomagnesemia is a common electrolyte disorder in pre-dialysis CKD patients. In this patient group, anemia is independently associated with hypomagnesemia.
- 3 September 2019
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 23 (11) , 1298-1305
Nondipping heart rate and associated factors in patients with chronic kidney disease
Nondipping heart rate (NHR) is a condition reported to be associated with cardiovascular events and cardiovascular mortality recently. We aimed to search whether there is difference among hypertensive patients with and without chronic kidney disease (CKD) in terms of NHR pattern and the factors associated with NHR in patients with CKD.
- 3 September 2019
- Published by Springer Nature in Clinical and Experimental Nephrology
- Vol. 23 (11) , 1298-1305
Nondipping heart rate and associated factors in patients with chronic kidney disease
Nondipping heart rate (NHR) is a condition reported to be associated with cardiovascular events and cardiovascular mortality recently. We aimed to search whether there is difference among hypertensive patients with and without chronic kidney disease (CKD) in terms of NHR pattern and the factors associated with NHR in patients with CKD.
- Open Access
- 29 April 2019
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 18 (1) , 16-22
The role of the neutrophil-to-lymphocyte ratio in predicting acute kidney injury in patients with acute pancreatitis
Giriş ve Amaç: Bir inflamasyon belirteci olan nötrofil lenfosit oranının çeşitli hastalıklarda akut böbrek hasarı gelişimini predikte ettiği gösterilmiştir. Biz de akut pankreatitte akut böbrek hasarını predikte etmede nötrofil lenfosit oranının rolünü araştırmayı amaçladık. Gereç ve Yöntem: Bu retrospektif çalışmaya Eylül 2016 ve Eylül 2018 yılları arasında Selçuk Üniversitesi Tıp Fakültesi’nde akut pankreatit tanısı ile takip edilen 186 hasta dahil edildi. Akut pankreatit tanısı ve şiddetinin belirlenmesinde Atlanta sınıflaması kullanıldı. Hastaların acile ilk başvuru sırasındaki laboratuvar değerleri ve prognostik skorlama sistemleri kullanıldı. Akut böbrek hasarı tanısı ve evrelemesi için KDIGO kriterleri kullanıldı. Bulgular: Çalışmaya alınan 186 hastanın yaş ortalaması 59.3±17.3 olup %59.7’si kadındı. Hastaların %26.3’ünde akut böbrek hasarı gelişmişti. Akut böbrek hasarı gelişen hastalar akut böbrek hasarı gelişmeyen hastalarla karşılaştırıldığında daha ileri yaşta oldukları ve hipertansiyon sıklığının daha fazla olduğu görüldü (her ikisi için p <0.001). Akut böbrek hasarı gelişen hastaların yatış süreleri ve yoğun bakım yatış süreleri anlamlı olarak uzun bulundu (her ikisi için p=0.001). Akut böbrek hasarı grubunda beyaz küre ve nötrofil sayıları anlamlı olarak yüksek bulunurken lenfosit sayısı anlamlı olarak düşük bulundu (her üçü için de p <0.001). Hastaneye kabulde bakılan nötrofil lenfosit oranı ve C-reaktif protein de akut böbrek hasarı grubunda anlamlı olarak daha yüksekti (her ikisi için p 0.05). Akut pankreatit hastalarında akut böbrek hasarı gelişimini bağımsız olarak predikte eden faktörleri belirlemek için yapılan multivariate regresyon analizinde yaş (OR: 0.964, %95 CI: 0.925-1.004, p: 0.008), nötrofil lenfosit oranı (OR: 1.096, %95 CI: 1.028-1.170, p: 0.005) ve BISAP skoru (OR: 6.582, %95 CI: 2.810-15.414, p <0.001) bağımsız etkili faktörler olarak belirlendi. Akut böbrek hasarını öngörmede nötrofil lenfosit oranının ROC eğrisinin altında kalan alan (area under curve) 0.813 (%95 CI 0.742-0.883), 11.24 kesme değeri için duyarlılık %73.4 ve özgüllük ise %81.4 olarak tespit edildi. Sonuç: Hastaneye kabulde bakılan nötrofil lenfosit oranı akut pankreatitli hastalarda akut böbrek hasarı gelişimini predikte etmede faydalı bir belirteç olabilir.
- 29 April 2019
- Published by Turkish Journal of Academic Gastroenterology in Akademik Gastroenteroloji Dergisi
- Vol. 18 (1) , 16-22
Open AccessThe role of the neutrophil-to-lymphocyte ratio in predicting acute kidney injury in patients with acute pancreatitis
Giriş ve Amaç: Bir inflamasyon belirteci olan nötrofil lenfosit oranının çeşitli hastalıklarda akut böbrek hasarı gelişimini predikte ettiği gösterilmiştir. Biz de akut pankreatitte akut böbrek hasarını predikte etmede nötrofil lenfosit oranının rolünü araştırmayı amaçladık. Gereç ve Yöntem: Bu retrospektif çalışmaya Eylül 2016 ve Eylül 2018 yılları arasında Selçuk Üniversitesi Tıp Fakültesi’nde akut pankreatit tanısı ile takip edilen 186 hasta dahil edildi. Akut pankreatit tanısı ve şiddetinin belirlenmesinde Atlanta sınıflaması kullanıldı. Hastaların acile ilk başvuru sırasındaki laboratuvar değerleri ve prognostik skorlama sistemleri kullanıldı. Akut böbrek hasarı tanısı ve evrelemesi için KDIGO kriterleri kullanıldı. Bulgular: Çalışmaya alınan 186 hastanın yaş ortalaması 59.3±17.3 olup %59.7’si kadındı. Hastaların %26.3’ünde akut böbrek hasarı gelişmişti. Akut böbrek hasarı gelişen hastalar akut böbrek hasarı gelişmeyen hastalarla karşılaştırıldığında daha ileri yaşta oldukları ve hipertansiyon sıklığının daha fazla olduğu görüldü (her ikisi için p <0.001). Akut böbrek hasarı gelişen hastaların yatış süreleri ve yoğun bakım yatış süreleri anlamlı olarak uzun bulundu (her ikisi için p=0.001). Akut böbrek hasarı grubunda beyaz küre ve nötrofil sayıları anlamlı olarak yüksek bulunurken lenfosit sayısı anlamlı olarak düşük bulundu (her üçü için de p <0.001). Hastaneye kabulde bakılan nötrofil lenfosit oranı ve C-reaktif protein de akut böbrek hasarı grubunda anlamlı olarak daha yüksekti (her ikisi için p 0.05). Akut pankreatit hastalarında akut böbrek hasarı gelişimini bağımsız olarak predikte eden faktörleri belirlemek için yapılan multivariate regresyon analizinde yaş (OR: 0.964, %95 CI: 0.925-1.004, p: 0.008), nötrofil lenfosit oranı (OR: 1.096, %95 CI: 1.028-1.170, p: 0.005) ve BISAP skoru (OR: 6.582, %95 CI: 2.810-15.414, p <0.001) bağımsız etkili faktörler olarak belirlendi. Akut böbrek hasarını öngörmede nötrofil lenfosit oranının ROC eğrisinin altında kalan alan (area under curve) 0.813 (%95 CI 0.742-0.883), 11.24 kesme değeri için duyarlılık %73.4 ve özgüllük ise %81.4 olarak tespit edildi. Sonuç: Hastaneye kabulde bakılan nötrofil lenfosit oranı akut pankreatitli hastalarda akut böbrek hasarı gelişimini predikte etmede faydalı bir belirteç olabilir.
- 1 March 2019
- Vol. 23 (5) , 2167-2173
Lipid accumulation product and visceral adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease
OBJECTIVE: The aim of this study was to assess the ability of lipid accumulation product (LAP) and visceral adiposity index (VAI) to predict metabolic syndrome (MetS) in patients with chronic kidney disease (CKD). We also aimed to determine whether VAI and LAP indices are superior to traditional body indices such as body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR). PATIENTS AND METHODS: This study was performed by retrospectively scanning the files of patients with stage 3-5 chronic renal failure who came for nephrology outpatient follow-up between January 2017 and December 2017. Metabolic syndrome was identified using the 2009 harmonized criteria. The receiver operating characteristic curve (ROC) was used to compare the area under the ROC curve (AUC) of each index. RESULTS: 247 patients were included in the analyses. The prevalence of MetS was 80.9%. LAP was determined as the optimal predictor in chronic kidney disease patients, with 0.864 AUC in females and 0.908 AUC in males. Optimal cutoff values for LAP were 33.5 in females and 36.6 in males. VAI was the second most optimal predictor, with 0.856 AUC in females and 0.888 AUC in males. Optimal cut-off values for VAI were 2.24 in females and 1.56 in males. CONCLUSIONS: LAP and VAI are effective indices for the prediction of MetS in patients with chronic kidney disease; LAP is the best index for the determination of MetS in both men and women.
- 1 March 2019
- Vol. 23 (5) , 2167-2173
Lipid accumulation product and visceral adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease
OBJECTIVE: The aim of this study was to assess the ability of lipid accumulation product (LAP) and visceral adiposity index (VAI) to predict metabolic syndrome (MetS) in patients with chronic kidney disease (CKD). We also aimed to determine whether VAI and LAP indices are superior to traditional body indices such as body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR). PATIENTS AND METHODS: This study was performed by retrospectively scanning the files of patients with stage 3-5 chronic renal failure who came for nephrology outpatient follow-up between January 2017 and December 2017. Metabolic syndrome was identified using the 2009 harmonized criteria. The receiver operating characteristic curve (ROC) was used to compare the area under the ROC curve (AUC) of each index. RESULTS: 247 patients were included in the analyses. The prevalence of MetS was 80.9%. LAP was determined as the optimal predictor in chronic kidney disease patients, with 0.864 AUC in females and 0.908 AUC in males. Optimal cutoff values for LAP were 33.5 in females and 36.6 in males. VAI was the second most optimal predictor, with 0.856 AUC in females and 0.888 AUC in males. Optimal cut-off values for VAI were 2.24 in females and 1.56 in males. CONCLUSIONS: LAP and VAI are effective indices for the prediction of MetS in patients with chronic kidney disease; LAP is the best index for the determination of MetS in both men and women.
- 12 September 2016
- Published by Springer Nature in International Urology and Nephrology
- Vol. 48 (12) , 2061-2068
Assessment of abdominal aortic calcification at different stages of chronic kidney disease
Vascular calcifications that may cause cardiovascular disease are highly prevalent in chronic kidney disease (CKD). In this study, we aimed to determine abdominal aorta calcifications (AAC) in predialysis and hemodialysis patients by lateral lumbar radiography and to investigate factors that were associated with the calcifications. Two hundred and fifty-nine adult chronic hemodialysis patients, 300 predialysis CKD patients and 60 healthy subjects with normal kidney function as a control group were enrolled in the study. Lateral lumbar radiography was used to measure AAC. Calcified deposits of the abdominal aorta wall at the level of the first through fourth lumbar vertebrae were graded by a 24-point scoring system. AAC prevalence (AAC score ≥1) was significantly different in hemodialysis, predialysis and control groups (71.8, 45.7 and 33.3 %, respectively; p < 0.001). AAC prevalence in CKD stages 1, 2, 3, 4 and 5 predialysis patients was 26.6, 43.3, 40, 58.3 and 55 %, respectively. AAC scores of the hemodialysis group were higher than of the predialysis group (p < 0.001) and the control group (p < 0.001). AAC scores of the predialysis group were not higher than of the control group (p = 0.314). AAC scores of the hemodialysis group were significantly higher than of the control group (p < 0.001) and stage 1 (p < 0.001), stage 2 (p = 0.001) and stage 3 predialysis groups (p = 0.002). Age (p < 0.001), presence of diabetes mellitus (p < 0.001) and serum phosphorus levels (p = 0.011) were found to be independent predictors of calcification in the hemodialysis group. Age (p < 0.001), serum phosphorus levels (p = 0.007) and history of cardiovascular disease (p = 0.014) were found to be independent predictors of calcification in the predialysis group. Abdominal aortic calcification is highly prevalent in the hemodialysis population. Strict phosphorus control should be implemented to the predialysis and hemodialysis patients.
- 12 September 2016
- Published by Springer Nature in International Urology and Nephrology
- Vol. 48 (12) , 2061-2068
Assessment of abdominal aortic calcification at different stages of chronic kidney disease
Vascular calcifications that may cause cardiovascular disease are highly prevalent in chronic kidney disease (CKD). In this study, we aimed to determine abdominal aorta calcifications (AAC) in predialysis and hemodialysis patients by lateral lumbar radiography and to investigate factors that were associated with the calcifications. Two hundred and fifty-nine adult chronic hemodialysis patients, 300 predialysis CKD patients and 60 healthy subjects with normal kidney function as a control group were enrolled in the study. Lateral lumbar radiography was used to measure AAC. Calcified deposits of the abdominal aorta wall at the level of the first through fourth lumbar vertebrae were graded by a 24-point scoring system. AAC prevalence (AAC score ≥1) was significantly different in hemodialysis, predialysis and control groups (71.8, 45.7 and 33.3 %, respectively; p < 0.001). AAC prevalence in CKD stages 1, 2, 3, 4 and 5 predialysis patients was 26.6, 43.3, 40, 58.3 and 55 %, respectively. AAC scores of the hemodialysis group were higher than of the predialysis group (p < 0.001) and the control group (p < 0.001). AAC scores of the predialysis group were not higher than of the control group (p = 0.314). AAC scores of the hemodialysis group were significantly higher than of the control group (p < 0.001) and stage 1 (p < 0.001), stage 2 (p = 0.001) and stage 3 predialysis groups (p = 0.002). Age (p < 0.001), presence of diabetes mellitus (p < 0.001) and serum phosphorus levels (p = 0.011) were found to be independent predictors of calcification in the hemodialysis group. Age (p < 0.001), serum phosphorus levels (p = 0.007) and history of cardiovascular disease (p = 0.014) were found to be independent predictors of calcification in the predialysis group. Abdominal aortic calcification is highly prevalent in the hemodialysis population. Strict phosphorus control should be implemented to the predialysis and hemodialysis patients.
- Open Access
- 12 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 144
Soluble TWEAK independently predicts atherosclerosis in renal transplant patients
Cardiovascular risk is increased in the early stages of chronic kidney disease (CKD) and also found to be ongoing in renal transplant (Rtx) patients. As a sign of atherosclerosis, increased carotid intima-media thickness (CIMT) has been widely accepted as a strong predictor of cardiovascular disease (CVD) and mortality in CKD patients. A novel markers, soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and neutrophil-to-lymphocyte ratio (NLR) were introduced as potential markers in inflammatory disorders including CKD. The role of Rtx in terms of atherogenesis is still unclear. We aimed to investigate the relationship between sTWEAK, NLR and CIMT in Rtx patients without overt CVD and to compare these results with those obtained from healthy subjects. Cross-sectional analysis in which CIMT measurements, NLR and serum TWEAK levels were assessed in 70 Rtx patients (29 females; mean age, 40.6 ± 12.4 years) and 25 healthy subjects (13 females, mean age; 37.4±8.8 years). sTWEAK levels were significantly decreased (p=0.01) and hs-CRP, NLR and CIMT levels of Rtx patients were significantly increased compared to healthy subjects (p<0.0001, p=0.001, p<0.0001, respectively). sTWEAK was also found to be decreased when eGFR was decreased (p=0.04 between all groups). CIMT was positively correlated with sTWEAK and NLR in Rtx patients (r=0.81, p<0.0001 and r=0.33, p=0.006, respectively). sTWEAK was also positively correlated with NLR (r=0.37, p=0.002). In the multivariate analysis only sTWEAK was found to be an independent variable of increased CIMT. sTWEAK might have a role in the pathogenesis of ongoing atherosclerosis in Rtx patients.
- 12 July 2013
- Published by Springer Nature in BMC Nephrology
- Vol. 14 (1) , 144
Open AccessSoluble TWEAK independently predicts atherosclerosis in renal transplant patients
Cardiovascular risk is increased in the early stages of chronic kidney disease (CKD) and also found to be ongoing in renal transplant (Rtx) patients. As a sign of atherosclerosis, increased carotid intima-media thickness (CIMT) has been widely accepted as a strong predictor of cardiovascular disease (CVD) and mortality in CKD patients. A novel markers, soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and neutrophil-to-lymphocyte ratio (NLR) were introduced as potential markers in inflammatory disorders including CKD. The role of Rtx in terms of atherogenesis is still unclear. We aimed to investigate the relationship between sTWEAK, NLR and CIMT in Rtx patients without overt CVD and to compare these results with those obtained from healthy subjects. Cross-sectional analysis in which CIMT measurements, NLR and serum TWEAK levels were assessed in 70 Rtx patients (29 females; mean age, 40.6 ± 12.4 years) and 25 healthy subjects (13 females, mean age; 37.4±8.8 years). sTWEAK levels were significantly decreased (p=0.01) and hs-CRP, NLR and CIMT levels of Rtx patients were significantly increased compared to healthy subjects (p<0.0001, p=0.001, p<0.0001, respectively). sTWEAK was also found to be decreased when eGFR was decreased (p=0.04 between all groups). CIMT was positively correlated with sTWEAK and NLR in Rtx patients (r=0.81, p<0.0001 and r=0.33, p=0.006, respectively). sTWEAK was also positively correlated with NLR (r=0.37, p=0.002). In the multivariate analysis only sTWEAK was found to be an independent variable of increased CIMT. sTWEAK might have a role in the pathogenesis of ongoing atherosclerosis in Rtx patients.